Drug Shortage Report for MYLAN-RIZATRIPTAN ODT
Report ID | 20578 |
Drug Identification Number | 02379198 |
Brand name | MYLAN-RIZATRIPTAN ODT |
Common or Proper name | RIZATRIPTAN ODT |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | RIZATRIPTAN |
Strength(s) | 5MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL |
Packaging size | 6BL |
ATC code | N02CC |
ATC description | ANTIMIGRAINE PREPARATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-09-08 |
Actual start date | 2017-09-11 |
Estimated end date | 2017-09-29 |
Actual end date | 2017-09-29 |
Shortage status | Resolved |
Updated date | 2017-09-30 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2017-09-30 | English | Compare |
v9 | 2017-09-29 | French | Compare |
v8 | 2017-09-29 | English | Compare |
v7 | 2017-09-28 | French | Compare |
v6 | 2017-09-28 | English | Compare |
v5 | 2017-09-13 | French | Compare |
v4 | 2017-09-13 | English | Compare |
v3 | 2017-09-09 | English | Compare |
v2 | 2017-08-29 | French | Compare |
v1 | 2017-08-29 | English | Compare |
Showing 1 to 10 of 10